BEXUMYCA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

BEXUMYCA Trademark

Serial Number: 98687171

BEXUMYCA is a trademark filed by Faraday Pharmaceuticals, Inc. on August 7, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Faraday Pharmaceuticals, Inc. (5 trademarks)

1616 Eastlake Avenue E, Suite 560
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

August 7, 2024

Registration Date

Not Registered

Published for Opposition

March 18, 2025

Goods & Services

Providing a website featuring information in the field of testing of pharmaceuticals; providing a website featuring information concerning medical research in the field of cardiac and skeletal muscle function diseases and disorders; research and development in the field of pharmaceuticals

Providing a website featuring information concerning medical diagnosis and treatment of cardiac and skeletal muscle function diseases and disorders

Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 15, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 15, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 10, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 13, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2025 CNEA
ASSIGNED TO EXAMINER
Feb 13, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Aug 7, 2024 NWAP